Novel tetravalent bispecific antibody, PSMA/TRAIL‑R2 REGULGENT™, induces selective tumor cell apoptosis without hepatotoxicity. - Nakayama M; Takagi-Maeda S; Machino Y; Nihira K; Inoue M; Takahashi N; Usami K (Oncology reports, 2025)